Covid-19 roundup: WHO recommends against 'high cost' remdesivir, disappointing Gilead; EU deals with Pfizer/BioNTech, CureVac top $10B — report
Veklury, or remdesivir, may be the first Covid-19 treatment to earn full approval at the FDA, after it won a full-throated endorsement from President …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.